PGC1α, a predicted target of all members of the miR-29 family (S13 Fig), drives many metabolic pathways in the cardiovascular system, and its cardiac-specific overexpression results in mitochondrial alterations in cardiomyocytes and in the development of cardiomyopathy [43–46]. This evidence concerns the gene PPARGC1A and cardiomyopathy.